Rami Mahfouz
American University of Beirut
222 Papers
946 Citations
Rami Mahfouz is an academic researcher from American University of Beirut. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 29, co-authored 205 publications. Previous affiliations of Rami Mahfouz include St. Jude Children's Research Hospital & American University.
Chat about Author
Papers
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.
Eng Juh Yeoh,Mary E. Ross,Sheila A. Shurtleff,W. Kent Williams,Divyen H. Patel,Rami Mahfouz,Frederick G. Behm,Susana C. Raimondi,Mary V. Relling,Anami Patel,Cheng Cheng,Dario Campana,Dawn Wilkins,Xiaodong Zhou,Jinyan Li,Huiqing Liu,Ching-Hon Pui,William E. Evans,Clayton W. Naeve,Limsoon Wong,James R. Downing +20 more
TL;DR: Oligonucleotide microarrays used to analyze the pattern of genes expressed in leukemic blasts from 360 pediatric ALL patients identified each of the prognostically important leukemia subtypes, and within some genetic subgroups, expression profiles identified those patients that would eventually fail therapy.
2K
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
Mary E. Ross,Xiaodong Zhou,Guangchun Song,Sheila A. Shurtleff,Kevin Girtman,W. Kent Williams,Hsi Che Liu,Rami Mahfouz,Susana C. Raimondi,Noel Lenny,Anami Patel,James R. Downing +11 more
TL;DR: Analysis of leukemic blasts from 132 diagnostic samples using higher density oligonucleotide arrays revealed new insights into the altered biology underlying these leukemias, including T-cell lineage ALL and hyperdiploid karyotypes with more than 50 chromosomes.
639
Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
TL;DR: Vascular endothelial growth factor-A is the most potent pro-angiogenic protein described to date and may reveal new targets for treating many diseases that are associated with this complex process.
407
Use of Chest Imaging in the Diagnosis and Management of COVID-19: A WHO Rapid Advice Guide.
Elie A. Akl,Ivana Blazic,Sally Yaacoub,Guy Frija,Roger Chou,John Adabie Appiah,Mansoor Fatehi,Nicola Flor,Eveline Hitti,Hussain Jafri,Zheng Yu Jin,Hans-Ulrich Kauczor,Michael Kawooya,Ella A. Kazerooni,Jane P. Ko,Rami Mahfouz,Valdair Francisco Muglia,Rose Nyabanda,Marcelo Sánchez,Priya B. Shete,Marina Ulla,Chuansheng Zheng,Emilie van Deventer,Maria del Rosario Perez +23 more
TL;DR: The rapid guide includes three diagnosis recommendations and four management recommendations that cover patients with suspected or confirmed COVID-19 with different levels of disease severity, throughout the care pathway from outpatient facility or hospital entry, to home discharge.
177
EGFR as a clinical marker in glioblastomas and other gliomas
TL;DR: This report serves as an update for the medical community about the role of EGFR gene alterations in gliomas and specifically glioblastomas, as a means for targeted treatment and prognosis.
155